Equities

Dominion Minerals Ltd

Dominion Minerals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.032
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Aug 28 2023.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Dominion Minerals Ltd had net income fall 176.25% from a loss of 872.75k to a larger loss of 2.41m despite a 74.78% increase in revenues from 33.82k to 59.11k.
Gross margin--
Net profit margin-4,626.16%
Operating margin-4,599.72%
Return on assets-56.67%
Return on equity-57.50%
Return on investment-57.50%
More ▼

Cash flow in AUDView more

In 2023, cash reserves at Dominion Minerals Ltd fell by 558.63k. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 549.62k for operations while cash used for investing totalled 7.87k.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0135
Tangible book value per share0.0135
More ▼

Balance sheet in AUDView more

Dominion Minerals Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio29.20
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in AUD

Year on year, growth in earnings per share excluding extraordinary items dropped -176.68%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-229.61
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.